Jiangsu Yangtze River Pharmaceutical Group Company Ltd. Sustainability Profile
Jiangsu Yangtze River Pharmaceutical Group Company Ltd., commonly referred to as Yangtze River Pharmaceutical, is a prominent player in the pharmaceutical industry, headquartered in Jiangsu, China. Established in 1994, the company has grown to become a leading manufacturer and supplier of a diverse range of pharmaceutical products, including active pharmaceutical ingredients (APIs) and finished dosage forms. With a strong focus on research and development, Yangtze River Pharmaceutical has achieved significant milestones, including numerous certifications and partnerships that enhance its market position. The company is renowned for its commitment to quality and innovation, offering unique products that cater to various therapeutic areas. As a key contributor to the global pharmaceutical landscape, Yangtze River Pharmaceutical continues to expand its operational reach, solidifying its reputation as a trusted name in healthcare solutions.
DitchCarbon Score
How does Jiangsu Yangtze River Pharmaceutical Group Company Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Jiangsu Yangtze River Pharmaceutical Group Company Ltd.'s score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Jiangsu Yangtze River Pharmaceutical Group Company Ltd.'s reported carbon emissions
Jiangsu Yangtze River Pharmaceutical Group Company Ltd., headquartered in China, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. As there are no emissions data or reduction initiatives available, it is unclear how Jiangsu Yangtze River Pharmaceutical Group is addressing climate change within the pharmaceutical industry context. The absence of reported emissions and targets may reflect a broader trend in the sector, where many companies are still developing their sustainability strategies. Overall, without specific emissions data or climate commitments, it is challenging to assess the company's environmental impact or its plans for future climate action.
How Carbon Intensive is Jiangsu Yangtze River Pharmaceutical Group Company Ltd.'s Industry?
How Carbon Intensive is Jiangsu Yangtze River Pharmaceutical Group Company Ltd.'s Location?
Jiangsu Yangtze River Pharmaceutical Group Company Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Jiangsu Yangtze River Pharmaceutical Group Company Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
